表紙
市場調査レポート

心臓再同期療法 (CRT) 装置の欧州市場 (2015〜2019年)

Cardiac Resynchronization Therapy Devices Market in Europe 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 335511
出版日 ページ情報 英文 98 Pages
即納可能
価格
本日の銀行送金レート: 1USD=107.50円で換算しております。
Back to Top
心臓再同期療法 (CRT) 装置の欧州市場 (2015〜2019年) Cardiac Resynchronization Therapy Devices Market in Europe 2015-2019
出版日: 2015年07月15日 ページ情報: 英文 98 Pages
概要

世界保健機構 (WHO) によると、心血管疾患は欧州諸国の死亡原因の過半数を占めています。欧州域内の主要5カ国では、心血管疾患に伴う経済的損失は合計901億米ドルに達しています (そのうち医療費は54%、生産性の損失は24%、インフォーマルケア関連は22%)。心臓再同期療法 (以下CRT) 装置は埋込型の医療機器で、微弱な電気的刺激を心筋に送ることで、心室の収縮を再同期させるというものです。CRTは心臓麻痺や不整脈に悩む患者にとっては効果的な治療法です。欧州諸国のCRT装置市場は2014〜2019年にかけて、8.09%の年平均成長率 (CAGR) で成長する見通しです。

当レポートでは、全世界の心臓再同期療法 (CRT) 装置の市場について分析し、技術的概要や市場の構造、市場規模の動向 (今後5年間の予測値)、製品別 (CRT除細動器/ペースメーカー)・地域別の詳細動向、市場の促進・抑制要因とその影響力、主要企業のプロファイル、今後の市場機会などを調査・推計しております。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 製品別の市場区分

  • CRT-D (両心室ペーシング機能付埋込型除細動器)
    • CRT-Dの利点とリスク
  • CRT-P (心臓再同期療法ペースメーカー)
    • CRT-Pの利点とリスク
  • 欧州のCRT-D市場
    • 市場規模と予測
  • 欧州のCRT-P市場
    • 市場規模と予測

第8章 欧州における心血管疾患の経済的負担

  • 欧州での医療費
  • 欧州上位5ヶ国での心血管疾患の経済的負担
  • 欧州の医療費償還シナリオ
  • 共同購買組織のベンダーに対する影響

第9章 国による市場区分

第10章 イタリアのCRT装置市場

  • 市場規模と予測
  • イタリアのCRT-D市場
  • イタリアのCRT-P市場

第11章 ドイツのCRT装置市場

第12章 フランスのCRT装置市場

第13章 英国のCRT装置市場

第14章 ベネルクス諸国のCRT装置市場

第15章 スカンジナビア諸国のCRT装置市場

第16章 スペインのCRT装置市場

第17章 購入基準

第18章 市場成長促進要因

第19章 成長促進要因とその影響

第20章 市場の課題

第21章 成長促進要因と課題の影響

第22章 市場動向

第23章 動向とその影響

第24章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • 企業合併・買収 (M&A)
  • 市場シェア分析
  • その他の有力ベンダー

第25章 主要ベンダーの分析

  • Boston Scientific
    • 主要データ
    • 事業概要
    • 事業区分
    • 部門別の市場収益額 (最新値)
    • 部門別の市場収益額 (前年度との比較)
    • 地域別の市場収益額 (最新値)
    • 事業戦略
    • 近年における発展
    • SWOT分析
  • Medtronic
  • St. Jude Medical

第26章 関連レポート

図表一覧

目次
Product Code: IRTNTR6450

About Cardiac Resynchronization Therapy Devices

According to WHO, cardiovascular diseases accounted for more than half of all deaths in the European region. The annual overall cost of cardiovascular diseases in the top five European countries is estimated to be $90.10 billion, of which 54% is attributed to healthcare costs, 24% to loss in productivity, and 22% to informal care.

CRT devices are implantable devices that are used to resynchronize contractions of the heart's ventricles by sending tiny electrical impulses to the muscles of the heart. CRT is an effective therapy for patients suffering from heart failure and arrhythmias.

Technavio's analysts forecast the cardiac resynchronization therapy devices market in Europe to grow at a CAGR of 8.09% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the cardiac resynchronization therapy devices market in Europe for the period 2015-2019. The market can be segmented into two: CRT-D devices and CRT-P devices.

Technavio's report, Cardiac Resynchronization Therapy Devices Market in Europe 2015-2019, has been prepared based on in-depth market analysis with inputs from industry experts. The report covers the top seven European countries. The report also includes a discussion of the key vendors operating in this market.

Key Countries

  • Benelux
  • France
  • Germany
  • Italy
  • Scandinavian
  • Spain
  • UK

Key Vendors

  • Boston Scientific
  • Medtronic
  • St. Jude Medical

Other Prominent Vendors

  • Biotronik
  • Cook Medical
  • Sorin Group
  • Spectranetics

Key Market Driver

  • Rise in Incidence of Cardiovascular Diseases in Europe
  • For a full, detailed list, view our report

Key Market Challenge

  • High Acceptance of Pacemakers and ICDs
  • For a full, detailed list, view our report

Key Market Trend

  • Focus on R&D
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Product

  • 07.1. CRT-D
    • 07.1.1. Benefits and Risks of CRT-D
  • 07.2. CRT-P
    • 07.2.1. Benefits and Risks of CRT-P
  • 07.3. CRT-D Market in Europe
    • 07.3.1. Market Size and Forecast
  • 07.4. CRT-P Market in Europe
    • 07.4.1. Market Size and Forecast

08. Economic Burden of Cardiovascular Diseases in Europe

  • 08.1. Healthcare Expenditure in Europe
  • 08.2. Economic Burden of Cardiovascular Diseases in Top Five European Countries
  • 08.3. Reimbursement Scenario in Europe
  • 08.4. Impact of Group Purchasing Organizations on Vendors

09. Market Segmentation by Country

10. CRT Devices Market in Italy

  • 10.1. Market Size and Forecast
  • 10.2. CRT-D Market in Italy
    • 10.2.1. Market Size and Forecast
  • 10.3. CRT-P Market in Italy
    • 10.3.1. Market Size and Forecast

11. CRT Devices Market in Germany

  • 11.1. Market Size and Forecast
  • 11.2. CRT-D Market in Germany
    • 11.2.1. Market Size and Forecast
  • 11.3. CRT-P Market in Germany
    • 11.3.1. Market Size and Forecast

12. CRT Devices Market in France

  • 12.1. Market Size and Forecast
  • 12.2. CRT-D Market in France
    • 12.2.1. Market Size and Forecast
  • 12.3. CRT-P Market in France
    • 12.3.1. Market Size and Forecast

13. CRT Devices Market in UK

  • 13.1. Market Size and Forecast
  • 13.2. CRT-D Market in UK
    • 13.2.1. Market Size and Forecast
  • 13.3. CRT-P Market in UK
    • 13.3.1. Market Size and Forecast

14. CRT Devices Market in Benelux

  • 14.1. Market Size and Forecast
  • 14.2. CRT-D Market in Benelux
    • 14.2.1. Market Size and Forecast
  • 14.3. CRT-P Market in Benelux
    • 14.3.1. Market Size and Forecast

15. CRT Devices Market in Scandinavia

  • 15.1. Market Size and Forecast
  • 15.2. CRT-D Market in Scandinavia
    • 15.2.1. Market Size and Forecast
  • 15.3. CRT-P Market in Scandinavia
    • 15.3.1. Market Size and Forecast

16. CRT Devices Market in Spain

  • 16.1. Market Size and Forecast
  • 16.2. CRT-D Market in Spain
    • 16.2.1. Market Size and Forecast
  • 16.3. CRT-P Market in Spain
    • 16.3.1. Market Size and Forecast

17. Buying Criteria

18. Market Growth Drivers

19. Drivers and Their Impact

20. Market Challenges

21. Impact of Drivers and Challenges

22. Market Trends

23. Trends and Their Impact

24. Vendor Landscape

  • 24.1. Competitive Scenario
    • 24.1.1. Key News
    • 24.1.2. Mergers and Acquisitions
  • 24.2. Market Share Analysis 2014
  • 24.3. Other Prominent Vendors

25. Key Vendor Analysis

  • 25.1. Boston Scientific
    • 25.1.1. Key Facts
    • 25.1.2. Business Overview
    • 25.1.3. Business Segmentation
    • 25.1.4. Business Segmentation by Revenue 2013
    • 25.1.5. Business Segmentation by Revenue 2012 and 2013
    • 25.1.6. Geographical Segmentation by Revenue 2013
    • 25.1.7. Business Strategy
    • 25.1.8. Recent Developments
    • 25.1.9. SWOT Analysis
  • 25.2. Medtronic
    • 25.2.1. Key Facts
    • 25.2.2. Business Overview
    • 25.2.3. Business Segmentation
    • 25.2.4. Revenue by Business Segmentation
    • 25.2.5. Revenue Comparison by Business Segmentation 2012 and 2013
    • 25.2.6. Revenue by Geographical Segmentation
    • 25.2.7. Business Strategy
    • 25.2.8. Key Developments
    • 25.2.9. SWOT Analysis
  • 25.3. St. Jude Medical
    • 25.3.1. Key Facts
    • 25.3.2. Business Description
    • 25.3.3. Business Segmentation
    • 25.3.4. Business Strategy
    • 25.3.5. Revenue Segmentation by Business
    • 25.3.6. Revenue by Geographical Segmentation
    • 25.3.7. Key Information
    • 25.3.8. SWOT Analysis

26. Other Reports in This Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Factors Contributing to Development of Cardiovascular Diseases
  • Exhibit 3: CRT Devices Market in Europe 2014-2019 ($ millions)
  • Exhibit 4: Segmentation of CRT Devices Market in Europe by Product
  • Exhibit 5: Segmentation of CRT Devices Market in Europe by Products 2014
  • Exhibit 6: CRT-D Market in Europe 2014-2019 ($ millions)
  • Exhibit 7: CRT-P Market in Europe 2014-2019 ($ millions)
  • Exhibit 8: Segmentation of CRT Devices Market in Europe by Product 2014-2019
  • Exhibit 9: Segmentation of CRT Devices Market in Europe by Product 2014-2019 ($ millions)
  • Exhibit 10: Economic Burden of Cardiovascular Diseases in Top Five European Countries 2014
  • Exhibit 11: Healthcare Coverage in Top Five European Countries
  • Exhibit 12: Change in Reported Average Real Prices of CRT Devices 2008-2013
  • Exhibit 13: Segmentation of CRT Devices Market in Europe by Country 2014
  • Exhibit 14: Segmentation of CRT-D Market in Europe by Country 2014-2019
  • Exhibit 15: Segmentation of CRT-P Market in Europe by Country 2014-2019
  • Exhibit 16: CRT Devices Market in Italy 2014-2019 ($ millions)
  • Exhibit 17: CRT-D Market in Italy 2014-2019 ($ millions)
  • Exhibit 18: CRT-P Market in Italy 2014-2019 ($ millions)
  • Exhibit 19: Segmentation of CRT Devices Market in Italy 2014-2019
  • Exhibit 20: Segmentation of CRT Devices Market in Italy 2014-2019 ($ millions)
  • Exhibit 21: CRT Devices Market in Germany 2014-2019 ($ millions)
  • Exhibit 22: CRT-D Market in Germany 2014-2019 ($ millions)
  • Exhibit 23: CRT-P Market in Germany 2014-2019 ($ millions)
  • Exhibit 24: Segmentation of CRT Devices Market in Germany 2014-2019
  • Exhibit 25: Segmentation of CRT Devices Market in Germany 2014-2019 ($ millions)
  • Exhibit 26: CRT Devices Market in France 2014-2019 ($ millions)
  • Exhibit 27: CRT-D Market in France 2014-2019 ($ millions)
  • Exhibit 28: CRT-P Market in France 2014-2019 ($ millions)
  • Exhibit 29: Segmentation of CRT Devices Market in France 2014-2019
  • Exhibit 30: Segmentation of CRT Devices Market in France 2014-2019 ($ millions)
  • Exhibit 31: CRT Devices Market in UK 2014-2019 ($ millions)
  • Exhibit 32: CRT-D Market in UK 2014-2019 ($ millions)
  • Exhibit 33: CRT-P Market in UK 2014-2019 ($ millions)
  • Exhibit 34: Segmentation of CRT Devices Market in UK 2014-2019
  • Exhibit 35: Segmentation of CRT Devices Market in UK 2014-2019 ($ millions)
  • Exhibit 36: CRT Devices Market in Benelux 2014-2019 ($ millions)
  • Exhibit 37: CRT-D Market in Benelux 2014-2019 ($ millions)
  • Exhibit 38: CRT-P Market in Benelux 2014-2019 ($ millions)
  • Exhibit 39: Segmentation of CRT Devices Market in Benelux 2014-2019
  • Exhibit 40: Segmentation of CRT Devices Market in Benelux 2014-2019 ($ millions)
  • Exhibit 41: CRT Devices Market in Scandinavia 2014-2019 ($ millions)
  • Exhibit 42: CRT-D Market in Scandinavia 2014-2019 ($ millions)
  • Exhibit 43: CRT-P Market in Scandinavia 2014-2019 ($ millions)
  • Exhibit 44: Segmentation of CRT Devices Market in Scandinavia 2014-2019
  • Exhibit 45: Segmentation of CRT Devices Market in Scandinavia 2014-2019 ($ millions)
  • Exhibit 46: CRT Devices Market in Spain 2014-2019 ($ millions)
  • Exhibit 47: CRT-D Market in Spain 2014-2019 ($ millions)
  • Exhibit 48: CRT-P Market in Spain 2014-2019 ($ millions)
  • Exhibit 49: Segmentation of CRT Devices Market in Spain 2014-2019
  • Exhibit 50: Segmentation of CRT Devices Market in Spain 2014-2019 ($ millions)
  • Exhibit 51: Snapshot of CRT Devices Market in Europe by Country 2014-2019
  • Exhibit 52: Key Takeaways: Boston Scientific
  • Exhibit 53: Key Takeaways: Medtronic
  • Exhibit 54: Key Takeaways: St. Jude Medical
  • Exhibit 55: Boston Scientific: Business Segmentation
  • Exhibit 56: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 57: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 ($ millions)
  • Exhibit 58: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 59: Medtronic: Business Segmentation
  • Exhibit 60: Medtronic: Revenue by Business Segmentation 2013
  • Exhibit 61: Medtronic: Revenue Comparison by Business Segmentation 2012 and 2013 ($ millions)
  • Exhibit 62: Medtronic: Revenue by Geographical Segmentation 2013
  • Exhibit 63: St. Jude Medical: Business Segmentation
  • Exhibit 64: St. Jude Medical: Revenue by Business Segmentation 2013
  • Exhibit 65: St. Jude Medical: Revenue by Geographical Segmentation 2012
Back to Top